Researcher
Joost Wauters
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Regenerative medicine, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory for Clinical Infectious and Inflammatory Disorders (Division)
Responsible
From1 Oct 2023 → Today - Processing Speech and Images (PSI) (Division)
Member
From1 Aug 2020 → 30 Jun 2000 - Laboratory of Intensive Care Medicine (Division)
Member
From1 Jan 2009 → 30 Sep 2011 - Laboratory for Clinical Infectious and Inflammatory Disorders (Division)
Member
From1 Dec 2004 → Today - ESAT - PSI, Processing Speech and Images (Division)
Member
From1 Nov 1999 → 30 Jun 2000 - Department of Electrical Engineering (ESAT) (Department)
Member
From1 Oct 1999 → 31 Jan 2000
Projects
1 - 10 of 21
- From bed to bench and back in viral-associated pulmonary aspergillosis: generation of pathophysiological insight and translation into host-based biomarkersFrom1 Oct 2023 → TodayFunding: FWO fellowships
- Unraveling the pathophysiology of Virus-Associated Pulmonary Aspergillosis using zebrafishFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- A novel integrated multi-omics based approach to the management of viral-associated pulmonary aspergillosis (VAPA)From1 Oct 2023 → TodayFunding: BOF - ZAP BOF mandates
- STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: STRADA-CEF trial.From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Unraveling the pathophysiology of Virus-Associated Pulmonary Aspergillosis: viruses and fungi combine efforts to make a perfect stormFrom19 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mold-active Azoles: Development, Validation and Implementation of strategies for Safe and Effective Dosing (M-ADVISED)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Clinical validation of antifungal dosing strategies in critically ill patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- The co-pathogenesis of severe influenza with invasive pulmonary aspergillosis.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Dual-band fibered confocal fluorescence microscope for the intravital interrogation of deep tissues and organs in real time and with cellular resolutionFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- A Pharmacometrics Approach to Guide Dose Optimization of anti-infective drugs in special patient populationsFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
21 - 30 of 139
- Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients(2022)
Authors: Marnick Clijsters, Wout Backaert, Dirk Jochmans, Lies Laenen, Yves Debaveye, Paul De Munter, Jan Gunst, Mark Jorissen, Katrien Lagrou, Johan Neyts, et al.
Pages: 3919 - + - Comment on: Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation(2022)
Authors: Beatrijs Mertens, Ruth Van Daele, Yves Debaveye, Joost Wauters, Christophe Vandenbriele, Matthias Gijsen
Pages: 3526 - 3527 - Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic study(2022)
Authors: Ruth Van Daele, Joost Wauters, Omar Elkayal, Erwin Dreesen, Yves Debaveye, Katrien Lagrou, Johan Maertens
- Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates(2022)
Authors: Kourosh Ahmadzadeh, Bram Boeckx, Amber De Visscher, Eline Bernaerts, Pierre Van Mol, Yannick Van Herck, Greet Hermans, Alexander Wilmer, Mieke Gouwy, Abhishek Garg, et al.
- Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study(2022)
Authors: Quentin Van Thillo, Iwein Gyselinck, Caroline Martens, Joost Wauters, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, Laurens Liesenborghs, Alexander Wilmer, et al.
- Autoantibodies against type I IFNs in patients with critical influenza pneumonia(2022)
Authors: Isabelle Meyts, Joost Wauters, Lore Vanderbeke, Simon Feys
- Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19(2022)
Authors: Caroline Martens, Pierre Van Mol, Joost Wauters, Els Wauters, Laurens Liesenborghs, Elisabeth Heylen, Sander Jansen, Sirima Kraisin, Robin Vos, Christophe Vandenbriele, et al.
- Ceftriaxone dosing based on the predicted probability of augmented renal clearance in critically ill patients with pneumonia(2022)
Authors: Erwin Dreesen, Matthias Gijsen, Omar Elkayal, Pieter Annaert, Yves Debaveye, Joost Wauters
Pages: 2479 - 2488 - The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluation(2022)
Authors: Joost Wauters, Yves Debaveye, Greet Hermans, Christophe Vandenbriele, Ruth Van Daele
- Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function(2022)
Authors: Matthias Gijsen, Omar Elkayal, Pieter Annaert, Ruth Van Daele, Yves Debaveye, Joost Wauters, Erwin Dreesen, Isabel Spriet
Pages: 53 - 62